Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6F. Hoffmann-La Roche

02 2Genentech

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Inavolisib

Brand Name : Itovebi

Dosage Form : Film Coated Tablet

Dosage Strength :

Packaging :

Approval Date : 18/07/2025

Application Number : 20240502000045

Regulatory Info : Approved

Registration Country : Sweden

blank

02

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Inavolisib

Brand Name : Itovebi

Dosage Form : Film Coated Tablet

Dosage Strength :

Packaging :

Approval Date : 18/07/2025

Application Number : 20240502000052

Regulatory Info : Approved

Registration Country : Sweden

blank

03

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Inavolisibum

Brand Name : Itovebi film-coated tablets

Dosage Form : Film Coated Tablet

Dosage Strength : 3mg

Packaging :

Approval Date : 31/01/2025

Application Number : 69792

Regulatory Info : Allowed

Registration Country : Switzerland

blank

04

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Inavolisibum

Brand Name : Itovebi

Dosage Form : Film Coated Tablet

Dosage Strength : 9mg

Packaging :

Approval Date : 31/01/2025

Application Number : 69792

Regulatory Info : Allowed

Registration Country : Switzerland

blank

05

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

INAVOLISIB

Brand Name : ITOVEBI

Dosage Form : TABLET

Dosage Strength : 3MG

Packaging :

Approval Date :

Application Number : 2555476

Regulatory Info : Prescription Recommended

Registration Country : Canada

blank

06

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

INAVOLISIB

Brand Name : ITOVEBI

Dosage Form : TABLET

Dosage Strength : 9MG

Packaging :

Approval Date :

Application Number : 2555484

Regulatory Info : Prescription

Registration Country : Canada

blank

07

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

INAVOLISIB

Brand Name : ITOVEBI

Dosage Form : TABLET;ORAL

Dosage Strength : 3MG

Packaging :

Approval Date : 2024-10-10

Application Number : 219249

Regulatory Info : RX

Registration Country : USA

blank

08

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

INAVOLISIB

Brand Name : ITOVEBI

Dosage Form : TABLET;ORAL

Dosage Strength : 9MG

Packaging :

Approval Date : 2024-10-10

Application Number : 219249

Regulatory Info : RX

Registration Country : USA

blank